H. M. Revankar and M. V. Kulkarni
Vol 000
m/zꢀ387 (M+., 3%); Anal. Calcd for C21H13N3O5 (%),
6-Chloro-4-((4-(((2-oxo-2H-chromen-4-yl)oxy)methyl)-1H-
1,2,3-triazol-1-yl)methyl)-2H-chromen-2-one (B3).
DMF,
Calcd: C, 65.12; H, 3.38; N, 10.85; Found: C, 65.11; H,
mp–293–295°C; yield–66%; IR (KBr, cmꢀ1), v = 1728
(lactone C=O); 1H NMR (400 MHz, DMSO-d6),
δ(ppm) = 5.4 (s, 2H, O─CH2), 5.9 (s, 1H, C3─H), 6.0
3.38; N, 10.81.
7-((1-(6-Chloro-2-oxo-2H-chromen-4-yl)-1H-1,2,3-triazol-4-
yl)methoxy)-8-hydroxy-4-methyl-2H-chromen-2-one (A4).
DMF, mp–248–250°C; yield–68%; IR (KBr, cmꢀ1),
0
(s, 2H, N─CH2), 6.1 (s, 1H, C3 ─H), 7.3–7.9 (m, 6H,
=
1732 (lactone C=O); 1H NMR (400 MHz,
Ar─H), 8.5 (s, 1H, tri-H) 13C–NMR (100 MHz,
DMSO-d6, δppm) 49.0, 62.6, 91.3, 115.0, 115.2, 116.4,
118.5, 118.8, 122.7, 124.1, 124.3, 126.3, 128.6, 132.2,
132.8, 141.7, 148.9, 151.7, 152.7, 158.8, 161.4, 164.2;
EI-MS: m/z–435(M+., 12%), 437 (M + 2+., 4%); Anal.
Calcd for C22H14ClN3O5 (%), Calcd: C, 60.63; H, 3.24;
v
DMSO-d6), δ(ppm) = 2.4 (d, 3H, ─CH3, J = 1.2 Hz), 5.4
0
(s, 2H, O─CH2), 6.4 (d, 1H, C3 ─H, J = 1.2 Hz),
6.9 (s, 1H, C3─H), 7.0–7.6 (m, 5H, Ar─H), 8.9 (s, 1H,
tri-H); 13C–NMR (100 MHz, DMSO-d6, δppm)
18.2, 61.4, 109.6, 111.4, 114.7, 115.6,117.6, 119.2, 119.8,
120.2,124.7, 126.4, 128.7, 133.0, 143.4, 144.5, 147.5,
152.3, 153.0, 154.1, 159.0, 159.8; EI-MS: m/z–451
(M+., 9%), 453 (M + 2+., 3%); Anal. Calcd for
C22H14ClN3O6 (%), Calcd: C, 58.48; H, 3.12; N, 9.30;
N, 9.64; Found: C, 60.61; H, 3.24; N, 9.60.
8-Hydroxy-7-((1-((7-methoxy-2-oxo-2H-chromen-4-yl)
methyl)-1H-1,2,3-triazol-4-yl)methoxy)-4-methyl-2H-chromen-
2-one (B4). DMF, mp–242–244°C; yield–62%; IR (KBr,
cmꢀ1), v = 1707 (lactone C=O); 1H NMR (400 MHz,
DMSO-d6), δ(ppm) = 2.3 (d, 3H, ─CH3, J = 1.2 Hz), 3.8
(s, 3H, 7─OCH3), 5.3 (s, 2H, O─CH2), 5.1 (s, 1H,
Found: C, 58.41; H, 3.10; N, 9.25.
4-Methyl-6-((1-(2-oxo-2H-chromen-4-yl)-1H-1,2,3-triazol-4-
yl)methoxy)-2H-chromen-2-one (A5).
DMF, mp–222–
224°C; yield–71%; IR (KBr, cmꢀ1), v = 1720 (lactone
C=O); 1H NMR (300 MHz, DMSO-d6), δ(ppm) = 2.4
(d, 3H, ─CH3, J = 1.2 Hz), 5.4 (s, 2H, O─CH2), 6.3
0
C3─H), 5.9 (s, 2H, N─CH2), 6.2 (d, 1H, C3 ─H,
J = 1.2 Hz), 7.1–7.5 (m, 5H, Ar─H), 8.4 (s, 1H, tri-H);
EI-MS: m/z–461(M+.); Anal. Calcd for C24H19N3O7 (%),
Calcd: C, 62.47; H, 4.15; N, 9.11; Found: C, 62.41; H,
0
(d, 1H, C3 ─H, J = 1.2 Hz), 6.5 (s, 1H, C3─H), 7.2–7.8
(m, 7H, Ar─H), 8.8 (s, 1H, tri-H); EI-MS: m/zꢀ401 (M+.,
4.10; N, 9.10.
2%); Anal. Calcd for C22H15N3O5; (%), Calcd: C, 65.83;
4-((4-(((6-Chloro-2-oxo-2H-chromen-4-yl)oxy)methyl)-1H-
1,2,3-triazol-1-yl)methyl)-2H-benzo[h]chromen-2-one (B5).
H, 3.77; N, 10.47; Found: C, 65.81; H, 3.67; N, 10.41.
7,8-Dimethyl-4-((4-(((2-oxo-2H-chromen-4-yl)oxy)methyl)-
1H-1,2,3-triazol-1-yl)methyl)-2H-chromen-2-one (B1).
DMF, mp–235–237°C; yield–66%; IR (KBr, cmꢀ1),
v
=
1716 (lactone C=O); 1H NMR (400 MHz,
DMF, mp–195–197°C; yield–68%; IR (KBr, cmꢀ1),
DMSO-d6), δ(ppm) = 5.3 (s, 2H, O─CH2), 5.8 (s, 1H,
v
=
1717 (lactone C=O); 1H NMR (400 MHz,
0
C3─H), 6.0 (s, 2H, N─CH2), 6.3 (s, 1H, C3 ─H), 7.1–7.9
(m, 9H, Ar─H), 8.4 (s, 1H, tri-H); EI-MS: m/z–485(M+.,
9%), 487 (M + 2+., 3%); Anal. Calcd for C26H16ClN3O5
(%), Calcd: C, 64.27; H, 3.32; N, 8.65; Found: C, 64.23;
H, 3.31; N, 8.65.
DMSO-d6), δ(ppm) = 2.2 (s, 3H, ─CH3), 2.3 (s, 3H,
─CH3), 5.4 (s, 2H, O─CH2), 5.8 (s, 1H, C3─H), 6.0
0
(s, 2H, N─CH2), 6.1 (s, 1H, C3 ─H), 7.2–7.7 (m, 6H,
Ar─H), 8.5 (s, 1H, tri-H); 13C–NMR (100 MHz,
DMSO-d6, δppm): 11.1, 19.8, 49.3, 62.6, 91.3, 112.6,
114.7, 115.0, 116.4, 121.4, 122.7, 124.0, 124.1, 125.7,
126.3, 132.7, 141.5, 142.0, 150.1, 151.2, 152.7, 159.5,
161.4, 164.2; EI-MS: m/zꢀ429 (M+., 5%); Anal. Calcd
for C24H19N3O5 (%), Calcd: C, 67.13; H, 4.46; N, 9.79;
4-Methyl-7-((1-(2-oxo-2-(2-oxo-2H-chromen-3-yl)ethyl)-1H-
1,2,3-triazol-4-yl)methoxy)-2H-chromen-2-one (C1).
DMF,
mp–220–222°C; yield–65%; IR (KBr, cmꢀ1), v = 1716
1
(C=O); H NMR (400 MHz, DMSO-d6), δ(ppm) = 2.4
(d, 3H, ─CH3), 5.3 (s, 2H, O─CH2), 6.0 (s, 2H,
0
Found: C, 67.10; H, 4.41; N, 9.72.
5,7-Dimethyl-4-((4-(((4-methyl-2-oxo-2H-chromen-6-yl)oxy)
methyl)-1H-1,2,3-triazol-1-yl)methyl)-2H-chromen-2-one
N─CH2), 6.2 (d, 1H, C3 ─H), 7.0–8.0 (m, 7H, Ar─H),
8.2 (s, 1H, C4─H) 8.8 (s, 1H, tri-H); 13C–NMR
(100 MHz, DMSO d6, δppm) 18.0, 58.2, 61.5, 101.5,
111.2, 112.6, 113.3, 116.6, 116.8, 117.9, 122.0, 125.1,
126.4, 131.1, 135.2, 148.5, 153.3, 154.6, 154.6, 158.5,
160.0, 161.0, 189.3; EI-MS: m/zꢀ443 (1%, M+.); Anal.
Calcd for C24H17N3O6 (%), Calcd: C, 65.01; H, 3.86; N,
(B2).
DMF, mp–201–203°C; yield–69%; IR (KBr,
cmꢀ1), v = 1716 (lactone C=O); 1H NMR (400 MHz,
DMSO-d6), δ(ppm) = 2.3 (s, 3H, ─CH3), 2.4 (d, 3H,
─CH3, J = 1.2 Hz), 2.6 (s, 3H, ─CH3), 5.3 (s, 2H,
O─CH2), 5.1 (s, 1H, C3─H), 6.1 (s, 2H, N─CH2), 6.4
9.48; Found: C, 65.01; H, 3.80; N, 9.41.
0
(d, 1H, C3 ─H, J = 1.2 Hz), 7.0–7.3 (m, 6H, Ar─H), 8.3
8-Hydroxy-7-((1-(2-(8-methoxy-2-oxo-2H-chromen-3-yl)-2-
oxoethyl)-1H-1,2,3-triazol-4-yl)methoxy)-4-methyl-2H-
chromen-2-one (C2). DMF, mp–223–225°C; yield–66%;
(s, 1H, tri-H); 13C–NMR (100 MHz, DMSO d6, δppm)
18.1, 20.6, 23.3, 52.2, 62.6, 109.6, 112.6, 114.7, 115.0,
116.4, 121.4, 122.7, 124.1, 124.7, 125.7, 126.3, 132.7,
141.5, 142.0, 150.1, 151.2, 152.7, 159.5, 159.7, 161.2;
EI-MS: m/zꢀ443 (M+., 7%); Anal. Calcd for
C25H21N3O5 (%), Calcd: C, 67.71; H, 4.77; N, 9.48;
Found: C, 67.69; H, 4.72; N, 9.41.
1
IR (KBr, cmꢀ1), v = 1724 (C=O); H NMR (400 MHz,
DMSO-d6), δ(ppm) = 2.4 (d, 3H, ─CH3), 3.6 (s, 3H,
─OCH3), 5.2 (s, 2H, O─CH2), 5.9 (s, 2H, N─CH2), 6.2
0
(d, 1H, C3 ─H), 7.3–7.8 (m, 5H, Ar─H), 8.3 (s, 1H,
C4─H) 8.8 (s, 1H, tri-H); EI-MS: m/zꢀ489(M+.); Anal.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet